🏠

🤯 AI Researchers Coming: 2028 & Beyond! 🚀

Tech

March 22, 2026| Author

🎧 Audio Summaries
English flag
French flag
German flag
Spanish flag
🛒 Shop on Amazon

🧠Quick Intel

  • OpenAI is developing a fully automated AI researcher, intended as the company’s “north star” for the next several years.
  • The autonomous AI research intern is designed to independently address complex research problems and represents a stepping stone towards a fully automated, multi-agent system anticipated for 2028.
  • Recent developments in psychedelic drug research, particularly the exploration of psilocybin, have generated excitement for potential treatments for depression, PTSD, addiction, and obesity.
  • Two studies released this week highlight the challenges inherent in conducting rigorous research with psychedelic substances.
  • The field of psychedelic drug research has, perhaps, become somewhat overhyped, emphasizing the need for cautious and carefully designed investigations.
  • The autonomous AI research intern is designed to fundamentally alter the landscape of scientific discovery.
  • The fully automated, multi-agent system is anticipated for deployment in 2028.

📝Summary


OpenAI is undertaking a significant project, aiming to develop an AI researcher, slated for debut in 2028. The company’s current focus involves constructing an autonomous AI research intern, planned for completion by September. This initiative follows a growing scientific interest in psychedelic drugs, particularly psilocybin, explored for treatments related to depression, PTSD, addiction, and obesity. Recent studies highlighted the challenges associated with researching these substances, indicating a complex and evolving area of scientific inquiry. The development of this AI researcher represents a substantial step in understanding this field.

💡Insights

▼


OPENAI’S AMBITIOUS AI RESEARCH GOAL
OpenAI is embarking on a significant new endeavor: the development of a fully automated AI researcher. This ambitious project, slated to be the company’s “north star” for the next several years, involves constructing an autonomous AI research intern designed to independently address complex research problems. This intern represents a crucial stepping stone towards the eventual deployment of a fully automated, multi-agent system anticipated for 2028. The goal is to create a system capable of self-directed research, fundamentally altering the landscape of scientific discovery.

PSYCHEDELIC DRUG RESEARCH: A CRITICAL ASSESSMENT
Recent developments in psychedelic drug research, particularly the exploration of compounds like psilocybin found in magic mushrooms, have generated considerable excitement. This interest spans potential treatments for a range of conditions, including depression, PTSD, addiction, and obesity. However, two studies released this week highlight the considerable challenges inherent in conducting rigorous research with these substances. These findings suggest that the field has, perhaps, become somewhat overhyped, emphasizing the need for cautious and carefully designed investigations to validate the potential benefits and understand the associated risks. (Blank Line)

Our editorial team uses AI tools to aggregate and synthesize global reporting. Data is cross-referenced with public records as of April 2026.

Related Articles